Report - Targeted Therapies - Klinik Schützen · Demetri, NEJM 2002 n = 147 PR = 53.7 %. Heinrich, JCO 2003 ... Toxizität „Targeted“ Therapy • Trastuzumab – Herz • Bevacizumab

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form